Basic info
Industry
pharmaceuticals
Sectors
Biotechnology
Pharmaceutical
Characterization of Hybridomas
Intrinsic Florescence Analysis
Process Development
Microbial and Mammalian Gene Expression
Antibody Display Technology
Over the Counter Product Development and Licensing
Preclinical Trial Material Manufacturing
Surface Plasmon Resonance/Biacore Analysis
Cell Based Assays and Screening
Protein Biochemistry and Therapeutics
Formulation Development
Protein and mAb Engineering
Diagnostic Development Support
Monoclonal Antibodies Derived From Murine Models
Stability Programs
mAb Based Discovery
Biophysical Characterization
including humanization
Microbiology
Analytical Chemistry
Medical
Assay Development and Validation
Date founded
2017
Funding rounds raised
Total raised
$65M
from 5 investors over 5 rounds
P
PMI BioPharma Solutions LLC raised $65M on December 1, 2022
Investors: Polaris Partners and Oak HC/FT
P
PMI BioPharma Solutions LLC raised $24M on May 27, 2021
Investors: Polaris Partners and Oak HC/FT
P
PMI BioPharma Solutions LLC raised undisclosed on July 16, 2020
Investors: Oak HC/FT